New York Professional Events List

4th Rx-to-OTC Switch Summit

Dec 04, 2017 - 07:00 AM - Dec 05, 05:00 PM
TBD Philadelphia, Philadelphia ,

Philadelphia ,
ZIP: Philadelphia
Phone: +1 929 900 1853

4th Rx-to-OTC Switch Summit

4th Rx-to-OTC Switch Summit

Switching drugs from prescription (Rx) to over-the-counter (OTC) status is a commercial strategy that has been growing in popularity. More than 20 products have been switched over to OTC during the past decade — and there has been a plethora of high-profile switch failures and disappointing results. Successful switches are as much an art as a science, and it has become increasingly apparent that switch teams must revise their best practices in strategy, marketing, sales, clinical research, regulatory affairs, medical writing, labeling and packaging if they are to effectively collaborate and lead an Rx product through the switch to OTC.

Now in its fourth consecutive year, ExL’s Rx-to-OTC Switch Summit is the most advanced thought leadership event experts can attend to discuss all aspects of a switch, from the NDA process to the final over-the-counter product; analyze current trends; and prepare for future switches. Whether you are exploring your chances of tapping into the very lucrative OTC marketplace or are an expert in the field, this conference will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests, maximizing the learning experience for overcoming the shared challenges of the industry. In addition, designated lunches and networking breaks will enhance the exchange of knowledge and foster future business partnerships.

Top Five Reasons to Attend

  1. Explore current trends and business models, and identify how to lead your Rx drug through the OTC switch journey
  2. Review the latest switches and learn from examples of successful and failed switches, as well as what caused their outcomes
  3. Hear how industry stakeholders can work together with key stakeholders — such as the FDA, retailers and government agencies — on the switch process and discuss the latest regulatory challenges and initiatives, including NSURE
  4. Understand the future of Rx-to-OTC switches and stay up to date with commercial strategies
  5. Network with leading industry professionals to exchange best practices for ensuring a seamless Rx-to-OTC switch, and brainstorm new marketing and branding strategies

Who Should Attend

This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas:

  • Rx-to-OTC Switches
  • Consumer Healthcare Products
  • Marketing/Brand Management/Product Management
  • Regulatory Affairs/Regulatory Processes
  • Clinical Development
  • Legal Affairs/Counsel/Regulatory Counsel
  • Medical/Scientific Affairs
  • Clinical Trials
  • Research and Development
  • Business Strategy
  • Labeling/Packaging
  • Drug Delivery Technology
  • Product Development
  • Corporate Development
This event is also of interest to:
  • Strategy and Marketing Consultants
  • Clinical Research Labs
  • CROs/CMOs
  • Drug After-Market Manufacturers/Suppliers
  • Legal/Regulatory Advisors
  • Statistical Service Providers
  • Marketing Organizations
Please contact the event manager Marilyn below for the following:
- For Tickets/Registrations,
- Discounts for registering  5 or more participants.
- If you company requires a price quotation.
Event Manager Contact:

marilyn.b.turner(at) or Contact:  +1 929 900 1853
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.
This Event Listing is Promoted by  New York Media Technologies LLC in association
with EXL Events Inc.


The 4th Rx-to-OTC Switch Summit agenda is currently under development. Sessions at this event will address a range of possible topics, such as:

  • The current Rx-to-OTC switch market environment
  • Rx categories that could become OTC switch areas and the next type of Rx drugs that are harder to switch
  • Shelf strategies and consumer behavioral patterns
  • The broad scope of issues organizations currently face during an OTC switch
  • How to enable new switch opportunities
  • A comparison of global Rx-to-OTC switch best practices
  • The current regulatory landscape and the frame of NSURE and BTC in the United States
  • Key marketing tools and strategies that require flawless execution when addressing the unique characteristics of a switch
  • Consumer behavior studies and how they translate to label optimization
  • Label comprehension and self-selection studies and their key objectives — the art of applying self-selection on complex indications on DFL
  • Packaging and labeling best practices for ensuring patient safety
  • Methods for building advocacy and neutralizing threats to your switch
  • Rx-to-OTC, OTC-to-Rx and drug-device combination product approvals
  • The role of patient education in creating self-efficient consumers

Keep watching this space for the latest updates on the agenda for ExL Events’ 4th Rx-to-OTC Switch Summit! If you have a question or comment you would like to be addressed at this event, or if you would like to get involved as a speaker or discussion leader, contact Koray Ozkal, Conference Production Director, at [email protected].

Event Categories
Keywords: fun, analyze, business , Clinical , conference , design , development , Fun , government , Health


Events Calendar

26 27 28 29 30 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6

Event Location


VIP Life Time Subscription to our Newsletters!

Forbes Women's Summit 2018
Disrupt SF 2018 - Brought to you by Techcrunch
U.S. Naval Institute Annual Meeting 2018
Breast Cancer Research Foundation
Children’s Health Fund
The World Energy Engineering Congress (WEEC)
                            Oct. 17-19, 2018
                            Charlotte, NC